Descripción del proyecto
Unas bombas microfluídicas innovadoras para el diagnóstico en el punto de atención
Los protocolos de diagnóstico a menudo requieren pequeñas muestras de plasma sanguíneo para poder diagnosticar enfermedades de forma rápida y eficaz. El objetivo del proyecto MagElastic, financiado con fondos europeos, es crear unos dispositivos sanitarios innovadores que mejoren el proceso de extracción y procesamiento de plasma sanguíneo para el diagnóstico en el punto de atención. La tecnología utilizada se basa en micromotores magnetoelásticos desarrollados recientemente. Estos pueden funcionar como bombas, válvulas y mezcladores microfluídicos en la manipulación del líquido a escala microscópica. El objetivo general es fundar una empresa emergente para que cree un componente de separación del plasma sanguíneo, lo cual facilitaría la producción de una gama de dispositivos para el diagnóstico de distintas enfermedades en el punto de atención.
Objetivo
The aim of MagElastic is to turn into a “ready for market” technology an innovation based on magnetoelastic micromotors, which was recently developed by FET-OPEN consortium ABIOMATER. It was demonstrated that such micromotors can function as microfluidic pumps, valves and stirrers, to manipulate liquids at microscopic scale. These properties show high potential in point-of-care (POC) diagnostics, since they allow for minimal volume of sample extraction, instantaneous application, and no reliance on the medical expertise or laboratory tools. The main objective of MagElastic is to set up a start-up/spin-off company for commercialising a blood plasma separation component which will enable to produce a range of point-of-care devices for diagnosis of many known illnesses. With only a prick of blood such a component can help saving a significant amount of time and costs, which are currently being lost in the necessity of involving specialised equipment and staff support to extract blood plasma. Because of it’s time efficiency, in some cases (such as Sepsis described below), such devices will allow to save lives. MagElastic will bring the current technology from TRL5/6 to TRL7 by engaging with early adopters that will test the new device in operational environment. Moreover MagElastic will pave the way for the commercialisation of the new device by meeting with potential customers, clients and commercial partners and facilitating access to potential investors. During the project, the University of Exeter and Platform Kinetics, owners of the results of the undergoing FET-OPEN project, will be supported by META Group, an experienced partner in exploitation of research results and access to investors.
Ámbito científico
Palabras clave
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-FETOPEN-4-2016-2017
Régimen de financiación
CSA - Coordination and support actionCoordinador
EX4 4QJ Exeter
Reino Unido